financetom
Business
financetom
/
Business
/
Tata Power completes sale of its defence biz to Tata Advanced Systems
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tata Power completes sale of its defence biz to Tata Advanced Systems
Nov 2, 2020 4:39 AM

Tata Power on Monday said it has completed the sale of its defence business to Tata Advanced Systems. Tata Advanced Systems is a wholly-owned subsidiary of Tata Sons. ”The sale was completed as per a Scheme of Arrangement, which was approved by the National Company Law Tribunal at Mumbai and Hyderabad in December 2019 and March 2020, respectively,” Tata Power said in a regulatory filing. The company said it is expected to receive an enterprise value of Rs 1,076 crore as an upfront payment.

Balance consideration is subject to completion of achieving certain milestones specified in the agreements, the company added. Tata Power said the sale of defence business is part of the company’s ongoing strategic plan to monetise its non-core assets and reduce overall leverage.

”The sale proceeds will help the company to reduce leverage and increase focus in the core business areas like renewable generation, distribution and new service-led businesses which will bring greater value for our shareholders,” Praveer Sinha, CEO and Managing Director, Tata Power said. Strategic Engineering Division (SED) is a non-core defence electronics division of the company, engaged in business of indigenous design, development, production, integration, supply and life cycle support of mission-critical defence systems.

The key products include manufacturing and assembling missile launchers, electronic warfare, night vision systems and gun systems. SED has three dedicated manufacturing units — Bangalore Electronic City, Vemagal in Karnataka (under construction) and an SEZ near Bengaluru (under construction).

First Published:Nov 2, 2020 1:39 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
EU vote on US trade deal is set to bring tariff peace, but for how long?
EU vote on US trade deal is set to bring tariff peace, but for how long?
Jun 15, 2026
* EU Parliament expected to vote on Tuesday to approve EU duty cuts * US will replace its tariffs with new system from July 24 * US demands EU concessions on non-tariff barriers * EU wants an end of higher tariffs on metal-content products By Philip Blenkinsop BRUSSELS, June 15 (Reuters) - The European Union is poised to implement the...
Market Chatter: Nvidia Seeks to Raise at Least $20 Billion From Bond Offering
Market Chatter: Nvidia Seeks to Raise at Least $20 Billion From Bond Offering
Jun 15, 2026
08:36 AM EDT, 06/15/2026 (MT Newswires) -- Nvidia ( NVDA ) is looking to raise at least $20 billion from its first corporate bond sale since 2021, Bloomberg reported Monday, citing people with direct knowledge of the matter. The company is marketing bonds in seven tranches with maturities ranging from two to 30 years, the report said, the report said,...
EU vote on US trade deal is set to bring tariff peace, but for how long?
EU vote on US trade deal is set to bring tariff peace, but for how long?
Jun 15, 2026
BRUSSELS, June 15 (Reuters) - The European Union is poised to implement the import duty cuts it agreed with U.S. President Donald Trump last year, averting at least for now another eruption of tariff conflict between the world's largest trading partners. The European Parliament will vote on Tuesday on legislation to fulfil the EU's side of the trade deal struck nearly...
Grifols Launches Fesilty Blood Clotting Concentrate in US
Grifols Launches Fesilty Blood Clotting Concentrate in US
Jun 15, 2026
08:33 AM EDT, 06/15/2026 (MT Newswires) -- Grifols ( GRFS ) has launched Fesilty, its new fibrinogen concentrate for the treatment of acute bleeding episodes in pediatric and adult patients with congenital fibrinogen deficiency, in the US, the company said Monday, Fesilty was approved by the US Food and Drug Administration in December, the company said. Congenital fibrinogen deficiency is...
Copyright 2023-2026 - www.financetom.com All Rights Reserved